Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
1,100.571,098.941,103.801,084.24
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
1,195.191,204.711,221.691,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
1,739.911,734.501,734.501,710.67
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
638.56640.21645.32638.69
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
831.57840.48844.16834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
213.36213.36215.79212.77
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
3,234.183,171.863,195.363,145.46
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
1,449.261,454.771,462.651,447.95
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
2,382.452,371.192,380.452,362.86
531146:BOM
Medicamen Biotech Ltd
₹249.60
+0.65%
(+1.60) 1D
Apr 29, 2:22:14 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531146...
Open
₹253.00
High
₹257.65
Low
₹249.60
Mkt. cap
3.40B
Avg. vol.
4.18K
Volume
80.00
Dividend
0.40%
Quarterly dividend
₹0.25
Ex dividend date
Sep 18, 2025
P/E ratio
36.95
52-wk high
₹456.20
52-wk low
₹220.00
EPS
₹6.75
Shares outstanding
11.70M
No. of employees
376
News stories
From sources across the web
About Medicamen Biotech Ltd
CEO-
Employees376
Founded1993
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
346.13M
435.15M
475.43M
474.43M
Cost of goods sold
156.33M
227.13M
231.53M
237.10M
Cost of revenue
156.33M
227.13M
231.53M
237.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
118.67M
80.90M
88.31M
83.73M
Operating expense
160.67M
175.18M
207.18M
206.51M
Total operating expenses
317.00M
402.31M
438.71M
443.61M
Operating income
29.13M
32.84M
36.72M
30.83M
Other non operating income
-9.88M
-
-
1.00K
EBT including unusual items
24.90M
21.31M
26.83M
21.11M
EBT excluding unusual items
24.88M
21.31M
26.83M
21.11M
Income tax expense
6.27M
5.30M
5.69M
4.76M
Effective tax rate
25.16%
24.89%
21.19%
22.56%
Other operating expenses
37.22M
76.26M
100.30M
104.51M
Net income
18.64M
21.53M
26.67M
21.87M
Net profit margin
5.38%
4.95%
5.61%
4.61%
Earnings per share
-
-
-
-
Interest and investment income
5.07M
-
-
-
Interest expense
-6.50M
-11.53M
-9.89M
-9.72M
Net interest expenses
-1.43M
-11.53M
-9.89M
-9.72M
Depreciation and amortization charges
4.79M
18.01M
18.57M
18.27M
EBITDA
46.41M
50.53M
55.01M
48.10M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more